Royalty Pharma (RPRX)
(Real Time Quote from BATS)
$26.81 USD
+0.37 (1.40%)
Updated Aug 13, 2024 09:50 AM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Brokerage Reports
0 items in cart
[RPRX]
Reports for Purchase
Showing records 21 - 40 ( 55 total )
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Biomedical and Genetics
We are dropping coverage due to the departure of covering analyst
Provider: Roth Capital Partners, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Biomedical and Genetics
Increasing PT to Reflect Improved Pipeline Outlook
Provider: Roth Capital Partners, Inc.
Analyst: JEN Y
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Biomedical and Genetics
The AUA Meeting Highlighted Infertility Concern Caused by TRT
Provider: Roth Capital Partners, Inc.
Analyst: JEN Y
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Industry: Medical - Biomedical and Genetics
Positive 301 Outcome Brightened Outlook for 302; Increase PT to $25
Provider: Roth Capital Partners, Inc.
Analyst: JEN Y
Industry: Medical - Biomedical and Genetics
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.